Nalu Medical, Inc. Appoints New Chief Executive Officer: Earl R. Fender Joins as President & CEO by Seini Moimoi | Apr 23, 2020 | Portfolio News
Axonics® Announces U.S. Food & Drug Administration Approval of Next Generation Implantable Neurostimulator by Seini Moimoi | Apr 14, 2020 | Portfolio News
Epirium Bio Receives FDA Orphan-Drug Designation for EB 002 ((+)-Epicatechin) for the Treatment of Duchenne and Becker Muscular Dystrophy by Seini Moimoi | Apr 14, 2020 | Portfolio News
89bio Announces Closing of Enrollment in its Phase 1b/2a NASH Trial and Reports New Preclinical Data Confirming BIO89-100’s Mechanism of Action Via Potent FGF Receptor Agonism by Seini Moimoi | Apr 13, 2020 | Portfolio News
Centers for Medicare & Medicaid Services Issues Product-Specific J-Code for XENLETA by Seini Moimoi | Apr 9, 2020 | Portfolio News
